Background: Enhanced expression of a kidney-specific sodium co-transporter (NKCC2: Na-K-2Cl co-transporter) in the thick ascending limb of Henle has been identified in rat models of congestive heart failure and liver cirrhosis, suggesting that high NKCC2 expression underlies edema formation. An increased abundance of NKCC2, however, has also been noted in rats with the syndrome of inappropriate secretion of antidiuretic hormone; hyponatremia without edema. In the present study, we examined NKCC2 expression in non-edematous disease, such as a brain infarction, and investigated the physiological and/or pathological characterization of NKCC2 expression. Methods: We initially examined NKCC2 expression in an animal model of brain infarction. Mongolian gerbils (around 60 g body weight) underwent bilateral clamping of the common carotid arteries for 5 min for the induction of brain infarction. NKCC2 and apical water channel (AQP2) protein levels in the collecting duct were examined by Western blotting in kidney tissues 2, 7, and 14 days after the brain infarction. Gerbils with brain infarction were then fed either a normal low-sodium diet (0.3 g/kg/day) or a high-sodium diet (3.0 g/kg/day), and body weight, urine volume and urinary osmolality were examined daily. Blood parameters were measured on day 14 after the brain infarction. Results: Histochemical examination of the brain confirmed the presence of brain infarction, as manifested by altered cresyl violet staining in the hippocampus. Protein levels of NKCC2 were significantly increased in gerbils with brain infarction on days 2 and 7 after brain infarction, whereas AQP2 protein signals remained unaltered. However, the increased NKCC2 intensity disappeared on day 14. Body weight gain was slightly, but significantly greater in gerbils with brain infarction than in sham-operated gerbils up to 7 days after the brain infarction. The high-sodium diet resulted in significant urinary concentration and enhanced weight gain in infarcted gerbils. Conclusion: We noted increased NKCC2 abundance in non-edematous disease, which enhanced body fluid accumulation, likely via the sodium loading-dependent concentration of the urine. These results suggest that the physiological process of edema formation is based on specific NKCC2 expression. The transient duration of these findings in the present animal model suggests two different characteristics of specific NKCC2 expression, an immediate, transient appearance as a common response in serious conditions and more chronic expression that leads to edema formation.

Keywords:
Edema, High-sodium diet, Urinary concentration, AQP2
1.
DiBona GF, Sawin LL: Role of renal nerve in sodium retention of cirrhosis and congestive heart failure. Am J Physiol 1991;260:R298–R305.
2.
Herman PJ, Swin LL, DiBona GF: Role of renal nerves in renal sodium retention of nephritic syndrome. Am J Physiol 1989;256:F823–F829.
3.
Marumo R., Kaizuma S, Nogae S, Kanazawa M, Kimura T, Saito T, Ito S, Matsubara M: Differential upregulation of rat Na-K-Cl co-transporter, rBSC1, mRNA in the thick ascending limb of Henle in different pathophysiological conditions. Kidney Int 1998;54:877–888.
4.
Jonassen TE, Brond L, Torp M, Graebe M, Nielsen S, Skott O, Marcussen N, Christensen S: Effects of renal denervation on tubular sodium handling in rats with CBL-induced liver cirrhosis. Am J Physiol Renal Physiol 2003;284:F555–F563.
5.
Molony DA, Reeves WB, Andreoli TE: Na+:K+:2Cl– cotransport and the thick ascending limb. Kidney Int 1989;36:418–426.
6.
Gamba G, Miyanoshita A, Lombardi M, Lytton J, Lee WS, Hediger MA, Hebert SC: Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride co-transporter family expressed in kidney. J Biol Chem 1994;269:17713–17722.
7.
Jonassen TE, Marcussen N, Haugan K, Skyum H, Christensen S, Andreasen F, Petersen JS: Functional and structural changes in the thick ascending limb of Henle’s loop in rats with liver cirrhosis. Am J Physiol 1997;273:R568–R577.
8.
Jonassen TE, Sorensen AM, Petersen JS, Andreasen F, Christensen S: Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride induced liver cirrhosis. Hepatology 2000;31:1224–1230.
9.
Kim G-H, Ecelbarger CA, Mitchell C, Packer RK, Wade JB, Knepper MA: Vasopressin increases Na-K-2Cl co-transporter expression in thick ascending limb of Henle’s loop. Am J Physiol 1999;276:F96–F103.
10.
Michimata M, Mizukami K, Suzuki M, Kazama I, Nakamura Y, Suzuki K, Yanagisawa T, Imai Y, Sasaki S, Matsubara M: Vasopressin-independent renal urinary concentration: increased rBSC1 and enhanced countercurrent multiplication. Kidney Int 2003;64:933–938.
11.
Kazama I, Hatano R, Michimata M, Suzuki K, Arata T, Suzuki M, Niyama N, Sato A, Ejima Y, Sasaki S, Matsubara M: BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats. Kidney Int 2005;67:1855–1867.
12.
Bartter FC, Schwartz WB: The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967;42:790–806.
13.
Araki T, Kato H, Shuto K, Fujiwara T, Itoyama Y: Effect of cerebral ischemia on dopamine receptor and uptake sites in gerbil hippocampus. Eur Neuropsychopharmacol 1997;7:275–282.
14.
Michimata M, Wang W, Fujita S, Mizutani H, Fujimori K, Satomi S, Ohta M, Ito S, Kimura T, Araki T, Imai Y, Matsubara M: Limited urinary concentration and damaged tubules in rats with a syngeneic kidney graft. Kidney Int 2001;60:672–679.
15.
Fushimi K, Uchida S, Hara Y, Hirata Y, Marumo F, Sasaki S: Cloning of apical membrane water channel of rat kidney collecting tubule. Nature 1993;361:549–552.
16.
Michimata M, Fujita S, Araki T, Mizukami K, Kazama I, Muramatsu Y, Suzuki M, Kimura T, Sasaki S, Imai Y, Matsubara M: Reverse pharmacological effect of loop diuretics and altered rBSC1 expression in rats with lithium nephropathy. Kidney Int2003;63:165–171.
17.
Nogae S, M, Kanazawa M, Honda S, Ohta M, Imai Y, Ito S, Matsubara M: Cardiac infarcts increase sodium transporter transcripts (rBSC1) in the thick ascending limb of Henle. Kidney Int 2000;57:2055–2063.
18.
Nielsen S, DiGiovanni SR, Christensen EI, Knepper MA, Harris HW: Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci USA 1993;90:11663–11667.
19.
Yamamoto T, Sasaki S, Fushimi K, Ishibashi K, Yaoita E, Kawasaki K, Fujinaka H, Marumo F, Kihara I: Vasopressin increases AQP-CD water channel in apical membrane of collecting duct cells in Brattleboro rats. Am J Physiol 1995;269:C655–C664.
20.
Hayashi M, Sasaki S, Tsuganezawa H, Monkawa T, Kitajima Y, Konishi K, Fushimi K, Marumo F, Saruta T: Expression and distribution of aquaporin of collecting duct are regulated by vasopressin V2 receptor in rat kidney. J Clin Invest 1994;94:1778–1783.
21.
Michimata M, Nogae S, Ohta M, Kaizuma K, Imai Y, Ito S, Matsubara M: Topographic distribution of aquaporin 2 mRNA in the kidney of dehydrated rats. Exp Nephrol 2000;8:28–36.
22.
Attmane-Elakeb A, Sibella V, Vernimmen C, Belenfant X, Hebert SC, Bichara M: Regulation by glucocorticoids of expression and activity of rBSC1, the Na+-K+-2Cl– co-transporter of medullary thick ascending limb. J Biol Chem 2000;275:33548–33553.
23.
Amal H, LeGoff C, Vernimmen C, Soleimani M, Paillard M, Bichara M: ANG II controls Na+-K+-2Cl– co-transporter via 20-HETE and PKC in medullary thick ascending limb. Am J Physiol 1998;274:C1047–C1056.
24.
Kwon TH, Nielsen J, Kim YH, Knepper MA, Frokiar J, Nielsen S: Regulation of sodium transporters in the thick ascending limb of rat kidney: response to angiotensin II. Am J Physiol Renal Physiol 2003;285:F152–F165.
25.
Fernandez-Llama P, Ecelbarger CA, Ware JA, Andrews P, Lee AJ, Turner R, Nielsen S, Knepper MA: Cyclooxygenase inhibitors increase Na-K-2Cl co-transporter abundance in thick ascending limb of Henle’s loop. Am J Physiol 1999;277:F219–F226.
26.
Horiuchi J, Takeuchi T: Descending pathways of powerful pressor response elicited by suprapontine cerebral ischemia in rabbits. Am J Physiol 1994;266:R1832–1839.
27.
Horiuchi J, Takeuchi T: Descending pathways of powerful pressor response elicited by suprapontine cerebral ischemia in rabbits. Am J Physiol 1994;266:R1832–1839.
28.
Michimata M, Kazama I, Mizukami K, Araki T, Nakamura Y, Suzuki M, Wang W, Fujimori K, Satomi S, Ito S, Imai Y, Matsubara M: Urinary concentration defect and limited expression of sodium co-transporter, rBSC1, in a rat model of chronic renal failure. Nephron Physiol 2003;93:34–41.
29.
Suzuki K, Hatano R, Michimata M, Kazama I, Suzuki M, Miyama N, Sato A, Satomi S, Ejima Y, Yanagisawa T, Matsubara M: Residual urinary concentrating ability and AQP2 expression in a rat model for chronic renal failure. Nephron Physiol 2005;99:16–22.
30.
Rosen S, Heyman SN: Difficulties in understanding human ‘acute tubular necrosis’: limited data and flawed animal models. Kidney Int 2001;60:1220–1224.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.